
zzso zzso zzso are capable of achieving durable symptomatic relief and significant clinical responses in certain zzso zzso we review the diverse direct and indirect mechanisms of zzso activity zzso by zzso as well as the hurdles that complicate their use as zzso in a broader range of zzso zzso is placed on recent clinical attempts to zzso the zzso survival factor effects in the bone zzso zzso in advanced prostate zzso The first clinical trials of this zzso factor zzso strategy zzso the ability of zzso to suppress the growth zzso zzso zzso zzso in combination with other drugs, such as zzso zzso and zzso acting zzso and at the bone zzso zzso These regimens restored zzso zzso responsiveness in stage D3 prostate cancer patients and successfully produced objective clinical responses while only mild zzso were zzso Furthermore, we focus on the zzso experimental data of a targeted zzso coupled to the zzso zzso zzso zzso The resulting zzso zzso has shown increased zzso potency with a zzso toxicity zzso The potential use of novel zzso as zzso drugs is discussed in relation to data suggesting other direct and indirect treatment approaches pertaining to the zzso zzso 

